0.03
+0.003(+13.64%)
Currency In USD
| Previous Close | 0.02 |
| Open | 0.02 |
| Day High | 0.03 |
| Day Low | 0.02 |
| 52-Week High | 0.05 |
| 52-Week Low | 0.02 |
| Volume | 55 |
| Average Volume | 121,426 |
| Market Cap | 1.89M |
| PE | -0.25 |
| EPS | -0.1 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.02 |
| Change | 0 |
If you invested $1000 in Galera Therapeutics, Inc. (GRTX) since IPO date, it would be worth $2.08 as of January 14, 2026 at a share price of $0.025. Whereas If you bought $1000 worth of Galera Therapeutics, Inc. (GRTX) shares 5 years ago, it would be worth $2.5 as of January 14, 2026 at a share price of $0.025.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
GlobeNewswire Inc.
Oct 22, 2025 11:00 AM GMT
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 mill
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
GlobeNewswire Inc.
Dec 31, 2024 12:00 PM GMT
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is Phase 1/2 trial of Nova Pharmaceutical’s Clinical Stage N